You are here

Treatment Gap in People with Newly Diagnosed Epilepsy in Australia

Description 
Epilepsy is one of the most common serious chronic neurological disorders and is estimated to affect approximately 68 million people worldwide. Antiepileptic drugs are the mainstay of treatment and suppress seizure occurrence. Epilepsy treatment gap is a recognised public health issue in resource-poor countries where up to 80% of people with epilepsy do not receive appropriate treatment. This phenomenon in resource-rich countries has not been well studied. Our recent study in Australia demonstrated 30% of adults with epilepsy did not commence treatment immediately at diagnosis. In this project, through linking to state and national databases, we will investigate the differences in outcomes between patients who were treated and not treated upon diagnosis. This project is suitable for students with background in clinical medicine, biomedical science and/or biostatistics.
Essential criteria: 
Minimum entry requirements can be found here: https://www.monash.edu/admissions/entry-requirements/minimum
Keywords 
Neurology, Medicine, Biostatistics, Epilepsy, Pharmacology
School 
Central Clinical School » Neuroscience
Available options 
Masters by research
Honours
BMedSc(Hons)
Time commitment 
Full-time
Physical location 
Alfred Research Alliance
Co-supervisors 
Dr 
Zhibin Chen

Want to apply for this project? Submit an Expression of Interest by clicking on Contact the researcher.